| |
Marie Kosco-Vilbois is NovImmune's Chief Scientific Officer, joining in 2002.
She was previously Head of Immunology and preclinical pharmacology at
the Serono Pharmaceutical Research Institute (1997-2001). As Head of
the Department, she and her team were responsible for taking four
biologicals into pre-clinical phase, one small molecular weight
compound through IND and Phase I, and one therapeutic protein into
Phase II. Prior to that, Marie was Senior Scientist and then Head of
Immunology at Glaxo-Welcomes' Research Institute in Geneva. Before
joining Glaxo, Marie Kosco-Vilbois was a Scientific Member of the Basel
Institute for Immunology. A US citizen, Marie holds a Bachelor of Arts
in Biology from Rutger's and received a PhD in Anatomy and Immunology
from the Medical College of Virginia in 1985. |
|
| Print |
|
|
|
|
| © NovImmune 2008 |
